Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.94
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company is headquartered in Westminster, Colorado.
See the full interactive analysis & chart →Informational only — not investment advice.